FORM 6-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

of the Securities Exchange Act of 1934

For the Month of November 2014

FORMULA SYSTEMS (1985) LTD.

(Translation of Registrant's Name into English)

5 HaPlada st., Or-Yehuda, Israel

(Address of Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F

Form 20-F  x Form 40-F ¨

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes  ¨ No x

If "Yes" is marked indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- ....................

Attached to Registrant's Form 6-K for the month of November 2014 and incorporated by reference herein is the Registrant's immediate report dated November 13, 2014.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to signed on its behalf by the undersigned, thereunto duly authorized.

FORMULA SYSTEMS (1985) LTD.

(Registrant)

By:/s/ Guy Bernstein

Guy Bernstein CEO

dated: November 13, 2014

PRESS RELEASE

Formula Systems Reports Third Quarter Results for 2014

Net income for the third quarter increased 20% year over year to $6.3 million

Or Yehuda, Israel, November 13, 2014 – Formula Systems (1985) Ltd. (NASDAQ: FORTY) a global information technology company principally engaged, through its subsidiary and affiliates, in providing software consulting services, developing proprietary software products, and providing computer-based business solutions, today announced its results for the third quarter and first nine months of 2014.

Financial Highlights for the Third Quarter Ended September 30, 2014

· Net income for the third quarter increased 20% to $6.3 million, or $0.43 per fully diluted share, compared to $5.2 million, or $0.36 per fully diluted share, in the same period last year.

· Revenues for the third quarter amounted to $153.4 million. Revenues for the third quarter showed a decrease due to the deconsolidation of Magic’s and Sapiens’ results of operations, which were previously consolidated during the third quarter of 2013, and which continue to be accounted for under the equity method of accounting. Formula’s non-GAAP comparable pro-forma revenues, had it continued to consolidate Magic’s and Sapiens’ results of operations for the third quarter of 2014, would have totaled $234.0 million, compared to $197.3 million in the same period last year, reflecting a year over year increase of 18.6%.

· Operating income for the third quarter amounted to $9.9 million. Operating income for the third quarter showed a decrease due to the deconsolidation of Magic’s and Sapiens’ results of operations, which were previously consolidated during the third quarter of 2013. Formula’s non-GAAP comparable pro-forma operating income, had it continued to consolidate Magic’s and Sapiens’ results of operations for the third quarter of 2014, would have totaled $17.9 million, compared to $14.8 million in the same period last year, reflecting a year over year increase of 20.9%. Formula held 45.2% and 48.4% of the outstanding shares of Magic and Sapiens, respectively, as of September 30, 2014.

Financial Highlights for the Nine-Month Period Ended September 30, 2014

· Net income for the first nine months of 2014 amounted to $66.3 million (or $4.57 per fully diluted share) compared to $14.3 million (or $0.99 per fully diluted share) in the same period last year. Net income for the nine-month period was positively impacted by a net gain of $61.4 million recorded in relation to Formula’s loss of control in Magic Software offset, in part, by the $5.3 million loss recorded as a result of the decrease of Formula’s beneficial ownership percentage in Sapiens from 48.8% to 46.95% due to the exercise of employee stock-based compensation and warrants.

· Revenues for the first nine months of 2014 amounted to $474.4 million. Revenues for the first nine-month period showed a decrease due to the deconsolidation of Magic’s and Sapiens’ results of operations, which were previously consolidated during the same period in 2013. Formula’s non-GAAP comparable pro-forma revenues, had it continued to consolidate Magic’s and Sapiens’ results of operations for the first nine months of 2014, would have totaled $684.5 million, compared to $587.2 million in the same period last year, reflecting a year over year increase of 16.6%.

· Operating income for the first nine months of 2014 amounted to $25.2 million. Operating income for the first nine-month period showed a decrease due to the deconsolidation of Magic’s and Sapiens’ results of operations, which were previously consolidated during the same period in 2013. Formula’s non-GAAP comparable pro-forma operating income, had it continued to consolidate Magic’s and Sapiens’ results of operations for the first nine months of 2014, would have totaled $44.7 million, compared to $43.4 million in the same period last year, reflecting a year over year increase of 2.8%.

· From August 21, 2014 through September 16, 2014, Formula purchased an aggregate of 736,862 Common Shares of Sapiens through broker-initiated and private transactions for an aggregate purchase price of US$5,757,192, which, combined with its previous holdings, represent 48.5% of the total issued and outstanding Common Shares of Sapiens.

· Consolidated cash and short-term and long-term investments in marketable securities totaled approximately $84.5 million as of September 30, 2014. Formula stand-alone net debt as of September 30, 2014 amounted to $25.0 million.

· Total equity as of September 30, 2014 was $472.0 million, representing 55% of Formula’s total assets.

Comments of Management

Commenting on the results, Guy Bernstein, CEO of Formula Systems, said, “We are pleased with our strong performance across our portfolio during the third quarter. Matrix continues to show steady top-line growth with revenues increasing in the third quarter by 14% year over year and during the nine-month period by 12% year over year. Matrix’s operating income grew 25% during the third quarter to reach $9.9 million as the company benefitted from increased demand for its services and increased its market share internationally and across all its Israeli markets. Backed with $85 million in cash and short-term investments, Magic maintained its double-digit growth momentum throughout the third quarter and the first nine months, with strong performance in sales and profitability across its products and professional services. Magic finished the first nine months with record revenues for the period of $121.8 million, up 17% over year, and record non-GAAP operating income for the period of $18.9 million, up 19% year over year, and reasserted its revenue guidance of $161 million to $165 million for the full-year 2014. Sapiens produced another record quarter with revenues of $40.4 million and non-GAAP operating income of $4.4 million, up 16.7% and 22.6%, respectively year over year. With total cash and investments in marketable securities of $78.4 million, Sapiens continues delivering strong revenue growth, improved profitability and cash flow, and an expanding pipeline of opportunities, allowing it to maintain confidence in its ability to deliver the high end of its guidance of $154 to $158 million of revenues for the full year".

About Formula

Formula Systems (1985) Ltd. is a global information technology company principally engaged, through its subsidiaries and affiliates, in providing software consulting services, developing proprietary software products, and providing computer-based business solutions.

For more information, visit www.formulasystems.com.

Press Contact:

Formula Systems (1985) Ltd.

+972-3-5389487

ir@formula.co.il

Except for any historical information contained herein, matters discussed in this press release might include forward-looking statements that involve a number of risks and uncertainties. Regarding any financial statements, actual results might vary significantly based upon a number of factors including, but not limited to, risks in product and technology development, market acceptance of new products and continuing product conditions, both locally and abroad, release and sales of new products by strategic resellers and customers, and other risk factors detailed in Formula's most recent annual report and other filings with the Securities and Exchange Commission. These forward-looking statements are made only as of the date hereof, and the Company undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.

FORMULA SYSTEMS (1985) LTD.

CONSOLIDATED CONDENSED STATEMENTS OF INCOME

U.S. dollars in thousands (except per share data)

	Nine months ended						Three months ended
	September 30,						September 30,
	2014			2013			2014			2013
	Unaudited						Unaudited
Revenues		474,369			587,213			153,363			197,285
Cost of revenues		393,068			445,233			128,571			149,113
Gross profit		81,301			141,980			24,792			48,172
Research and development costs, net		787			11,859			-			3,879
Selling, general and administrative expenses		55,277			86,770			14,892			29,529
Other income, net		4			2			1			4
Operating income		25,241			43,353			9,901			14,768
Financial expenses, net		(4,683	)		(5,013	)		(160	)		(1,447	)
Income before taxes on income		20,558			38,340			9,741			13,321
Taxes on income		7,130			5,641			2,693			1,602
Income after taxes		13,428			32,699			7,048			11,719
Equity in gains (losses) of affiliated companies, net		63,391			(91	)		2,554			(68	)
Net income		76,819			32,608			9,602			11,651
Change in redeemable non controlling interests		480			1,745			175			388
Net income attributable to non-controlling interests		10,088			16,527			3,173			6,048
Net income attributable to Formula's shareholders		66,251			14,336			6,254			5,215
Earnings per share (basic)		4.75			1.05			0.45			0.38
Earnings per share (diluted)		4.57			0.99			0.43			0.36
Number of shares used in computing earnings per share (basic)		13,929,326			13,685,667			13,946,869			13,806,522
Number of shares used in computing earnings per share (diluted)		14,424,976			14,085,244			14,428,288			14,195,053

FORMULA SYSTEMS (1985) LTD.

CONSOLIDATED CONDENSED BALANCE SHEETS

U.S. dollars in thousands        

	September 30,		Dec 31,
	2014		2013
	(Unaudited)
ASSETS
CURRENT ASSETS:
Cash and cash equivalents		67,071		82,123
Marketable securities		16,865		17,956
Short-term deposit		13		672
Trade receivables		140,704		193,582
Other accounts receivable and prepaid expenses		29,506		36,488
Inventories		2,368		2,407
Total current assets		256,527		333,228
LONG-TERM INVESTMENTS:
Marketable securities		547		520
Deferred Taxes		14,722		13,152
Prepaid expenses and other accounts receivable		8,960		8,761
Total  Long-Term Investments		24,229		22,433
INVESTMENTS IN AFFILIATED COMPANIES		333,738		161,501
SEVERANCE PAY FUND		57,322		68,148
PROPERTY, PLANTS AND EQUIPMENT, NET		15,996		19,408
NET INTANGIBLE ASSETS AND GOODWILL		166,440		267,077
TOTAL  ASSETS		854,252		871,795
CURRENT LIABILITIES:
Liabilities to banks		30,105		35,636
Trade payables		38,622		52,645
Deferred revenues		23,613		28,454
Other accounts payable		61,655		89,670
Dividend payable		-		4,565
Total current liabilities		153,995		210,970
LONG-TERM LIABILITIES:
Liabilities to banks and others		112,037		62,447
Deferred taxes		26,711		8,157
Deferred revenue		5,504		4,990
Other long-term payables		2,104		4,289
Accrued severance pay		69,767		81,258
Total long-term liabilities		216,123		161,141
REDEEMABLE NON-CONTROLING INTEREST		12,154		23,529
EQUITY
Formula shareholders' equity		383,514		319,341
Non-controlling interests		88,466		156,814
Total equity		471,980		476,155
TOTAL LIABILITIES AND EQUITY		854,252		871,795

*) Restated due to a misstatement in revenues recognized in Matrix in 2009 until 2013 (Decreasing Revenues in 2011,2012 and 2013 $1.7, $1.8 and $0.8 million respectively;  Decreasing net income in  2011,2012

And the following effect on the consolidated condensed balance sheet:     

As of December 31, 2013
	As previously reported		Adjustment		As adjusted
Trade receivables		201,144		-7,562		193,582
Other accounts receivable		34,609		1,876		36,485
Formula shareholders' equity		322,185		-2,844		319,341
Non-controlling interests		159,653		-2,839		156,814